Lucid Diagnostics Inc. Common Stock
Symbol: LUCD (NASDAQ)
1.01
▲ (2.95%) 0.029
Company Description:
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Key Stats
- Today's Open: $0.992
- Today's High: $1.027
- Today's Low: $0.985
- Today's Volume: 759.32K
- Yesterday Close: $0.9811
- Yesterday High: $1.015
- Yesterday Low: $0.98
- Yesterday Volume: 620.96K
- Last Min Volume: 70
- Last Min High: $1.01
- Last Min Low: $1.01
- Last Min VWAP: $1.01
Company Profile
- Name: Lucid Diagnostics Inc. Common Stock
- Website: https://www.luciddx.com
- Listed Date: 2021-10-14
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001799011
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $103.93M
- Round Lot: 100
- Outstanding Shares: 101.89M
- Asset Type: CS
RECENT FILINGS FOR LUCD
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | 8-K | View |
| 2025-08-12 | 10-Q | View |
| 2025-06-18 | 8-K | View |
| 2025-06-03 | 424B3 | View |
| 2025-05-30 | EFFECT | View |
| 2025-05-30 | 8-K | View |
| 2025-05-30 | 424B5 | View |
| 2025-05-27 | CORRESP | View |
| 2025-05-27 | UPLOAD | View |
| 2025-05-23 | 4/A | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | S-3 | View |
| 2025-05-14 | 8-K | View |
| 2025-05-13 | 10-Q | View |
| 2025-04-30 | DEFA14A | View |
| 2025-04-30 | ARS | View |
| 2025-04-30 | DEF 14A | View |
| 2025-04-25 | 8-K | View |
| 2025-04-18 | PRE 14A | View |
| 2025-04-11 | 8-K | View |
Latest News on LUCD